You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 5, May 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Subsyndromal Symptoms in Bipolar Disorder

A Comparison of Standard and Low Serum Levels of Lithium

Martin B. Keller, MD; Philip W. Lavori, PhD; John M. Kane, MD; Alan J. Gelenberg, MD; Jerrold F. Rosenbaum, MD; Elizabeth A. Walzer; Lori A. Baker, MA

Arch Gen Psychiatry. 1992;49(5):371-376.


Abstract

• Ninety-four patients with bipolar disorder participating in a random-assignment, double-blind, prospective maintenance trial of standard- (0.8 to 1.0 mmol/L) vs low-range (0.4 to 0.6 mmol/L) serum lithium levels were assessed to determine the presence and significance of subsyndromal symptoms during periods of remission and recovery. A significant relationship was found between prescribed serum lithium level and the probability of major affective relapse and the occurrence of subsyndromal symptoms. Patients given lithium carbonate to achieve low-range levels had 2.6 times the risk of major affective relapse as those given lithium for standard-range levels and nearly twice the risk of developing subsyndromal symptoms. Patients given the low-range therapy showed a greater variance in weekly Psychiatric Status Rating measures, and their symptoms were more likely to worsen at any time than were symptoms in their standard-level group counterparts. The first occurrence of subsyndromal symptoms increased the risk of major affective relapse fourfold. Following the onset of subsyndromal symptoms, the patients originally randomized to receive standard-range lithium therapy were still better protected from relapse than were patients randomized to receive low-range lithium treatment. Patients were two times more likely to develop depressive than hypomanic symptoms between acute episodes of illness. However, onset of hypomanic symptoms predicted subsequent major affective relapse twice as strongly as did depressive symptoms. Seventy-six percent of patients who became hypomanic had a major affective relapse, compared with 39% of patients who were subclinically depressed.



Author Affiliations

From the Department of Psychiatry and Human Behavior, Brown University, Providence, RI (Drs Keller and Lavori and Ms Baker); the Hillside Hospital of Long Island Jewish Medical Center and the Albert Einstein College of Medicine, New York, NY (Dr Kane); the Department of Psychiatry, University of Arizona, Tucson (Dr Gelenberg); and the Department of Psychiatry, Massachusetts General Hospital and Harvard University, Boston (Dr Rosenbaum and Ms Walzer).


Footnotes

Accepted for publication September 24, 1991.

Reprint requests to Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02912 (Dr Keller).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Residual Symptom Recovery From Major Affective Episodes in Bipolar Disorders and Rapid Episode Relapse/Recurrence
Judd et al.
Arch Gen Psychiatry 2008;65:386-394.
ABSTRACT | FULL TEXT  

Cognitive-Behavioural Therapy for Severe and Recurrent Bipolar Disorders: Randomised Controlled Trial
Scott et al.
Focus 2007;5:64-72.
ABSTRACT | FULL TEXT  

Influence of sub-syndromal symptoms after remission from manic or mixed episodes
TOHEN et al.
Br. J. Psychiatry 2006;189:515-519.
ABSTRACT | FULL TEXT  

Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Perlis et al.
Focus 2006;4:553.
FULL TEXT  

Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder
Paykel et al.
Br. J. Psychiatry 2006;189:118-123.
ABSTRACT | FULL TEXT  

Cognitive-behavioural therapy for severe and recurrent bipolar disorders: Randomised controlled trial
SCOTT et al.
Br. J. Psychiatry 2006;188:313-320.
ABSTRACT | FULL TEXT  

Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Perlis et al.
Am. J. Psychiatry 2006;163:217-224.
ABSTRACT | FULL TEXT  

Clinical Course of Children and Adolescents With Bipolar Spectrum Disorders
Birmaher et al.
Arch Gen Psychiatry 2006;63:175-183.
ABSTRACT | FULL TEXT  

Past, Present, and Future Directions for Defining Optimal Treatment Outcome in Depression: Remission and Beyond
Keller
JAMA 2003;289:3152-3160.
ABSTRACT | FULL TEXT  

A 25-Year-Old Woman With Bipolar Disorder
Sachs
JAMA 2001;285:454-462.
FULL TEXT  

Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment
Perry et al.
BMJ 1999;318:149-153.
ABSTRACT | FULL TEXT  

Lithium Maintenance Treatment of Depression and Mania in Bipolar I and Bipolar II Disorders
Tondo et al.
Am. J. Psychiatry 1998;155:638-645.
ABSTRACT | FULL TEXT  

12-Month Outcome of Patients With Bipolar Disorder Following Hospitalization for a Manic or Mixed Episode
Keck et al.
Am. J. Psychiatry 1998;155:646-652.
ABSTRACT | FULL TEXT  

Current Therapeutic Profile of Lithium
Gershon and Soares
Arch Gen Psychiatry 1997;54:16-20.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.